Lifestyle and genetic factors are considered to play a major role in "Asian paradox"
News-Medical-Net Wed, 28 Oct 2009 22:01 PM PDT
Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains. Moreover, in Asian countries such as Indonesia, Japan, China, and Thailand, where the H. pylori infection rates are similar, there is a significant difference ... |
Breast cancer can also strike men
The Oklahoman Wed, 28 Oct 2009 22:00 PM PDT
This year’s Susan G. Komen Race for the Cure in Oklahoma City raised more than $250,000 for breast cancer research. And the foundation is still raising money with its "2010 Men of Oklahoma†calendar. Though not as sexy as the "Save the Ta-Tas†T-shirts, the calendar features prominent Oklahoma men including University of Oklahoma football heroes Josh Heupel, Tinker Owens and Steve Owens and ... |
Knowing the fat facts can lower the risk
The Meridian Star Wed, 28 Oct 2009 21:58 PM PDT
To help decrease the incidence of breast cancer, knowing the "fats" is as crucial as knowing the facts. According to the American Cancer Society, being overweight or obese has been found to increase breast cancer risk, especially for women after menopause. |
West Bulletin Board
Pittsburgh Post-Gazette Wed, 28 Oct 2009 21:56 PM PDT
Collier -- The Samuel J. Foundation, which assists pediatric cancer patients, will sponsor "Scrappin' for Sam," a scrapbooking event, from 9 a.m. to 5 p.m. Nov. 7. |
New Zealand ice cream could lick chemotherapy side-effects
EARTHtimes.org Wed, 28 Oct 2009 21:52 PM PDT
Wellington - An ice cream developed in New Zealand is undergoing trials to see if it can combat some of the unpleasant side-effects of chemotherapy for cancer patients, it was reported on Thursday. Developed by the Fonterra dairy company and Auckland... |
Oncodesign to develop experimental cancer models for sanofi-aventis
PharmaBiz Wed, 28 Oct 2009 21:51 PM PDT
Oncodesign Biotechnology, a specialist in the identification of novel cancer therapies, has signed a two-year service contract with sanofi-aventis under which it is to supply and develop exclusive, experimental models in different types of cancer for the Paris-based pharmaceutical company. |
Stynes inspired by kids in cancer fight
Brisbane Times Wed, 28 Oct 2009 21:49 PM PDT
Cancer-stricken Melbourne president Jim Stynes says he draws inspiration from children winning their fight against the disease as he continues his own battle. |
New anti-cancer medications may help in managing cancerous conditions
News-Medical-Net Wed, 28 Oct 2009 21:48 PM PDT
Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. |
| |
|
No comments:
Post a Comment